Polymethoxylated flavones for treating insulin resistance
CA 2445963 A1 · Owner: Guthrie, Najla · Inventors: Kurowska, Elzbieta Maria; Guthrie, Najla
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods for treating metabolic abnormalities arising from insulin resistance comprises the administration of tangeretin or a mixture of various polymethoxylated flavones (PMFs) are described. The PMFs are administered in various manners including orally. Supplementation with PMF to individuals affected by insulin resistance syndrome results in normalization of metabolic activity and improved glucose metabolism.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 2, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 2, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 2, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.